Challenges of biological valve development

Interventional Cardiology (London)

Volumn 5, Issue 3, 2013, Pages 319-334

  Spoon, Daniel B ^a   Tefft, Brandon J ^a   Lerman, Amir ^a   Simari, Robert D ^a  

^a MAYO CLINIC   (United States)

Author keywords

aortic valve; bioreactor; decellularization; heart valve; pulmonic valve; recellularization; scaffold; stem cell; tissue engineering

Indexed keywords

ANTIVITAMIN K; COLLAGEN; FIBRIN; GLUTARALDEHYDE; GLYCOSAMINOGLYCAN; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYURETHAN; PYROLYTIC CARBON; TISSUE SCAFFOLD;

ANTICOAGULATION; ANTIGENICITY; AORTA STENOSIS; AORTA VALVE REPLACEMENT; BIOCOMPATIBILITY; BIOREACTOR; BIOREACTOR DESIGN; CELL DIFFERENTIATION; CELL MIGRATION; CELL TYPE; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL (TOPIC); COLLAGEN SYNTHESIS; CONDITIONING; ELECTROSPINNING; FEEDBACK SYSTEM; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MECHANICAL HEART VALVE; MECHANICAL STRESS; MICROTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PULMONARY VALVED CONDUIT; QUALITY OF LIFE; REVIEW; ROSS PROCEDURE; SHEAR STRESS; SOLID PHASE EXTRACTION; SURVIVAL; THROMBOEMBOLISM; TISSUE ENGINEERING;

EID: 84878851270     PISSN: 17555302     EISSN: 17555310     Source Type: Journal    
DOI: 10.2217/ica.13.21     Document Type: Review

References (134)

1. Schoen FJ. Evolving concepts of cardiac valve dynamics: The continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 118(18), 1864-1880 (2008
2. Aikawa E, Whittaker P, Farber M et al. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: Implications for postnatal adaptation, pathology, and tissue engineering. Circulation 113(10), 1344-1352 (2006
3. Hinton RB, Yutzey KE. Heart valve structure and function in development and disease. Ann. Rev. Physiol. 73, 29-46 (2011
4. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the veterans affairs randomized trial. J. Am. Coll. Cardiol. 36(4), 1152-1158 (2000
5. Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363(17), 1597-1607 (2010
6. BloomfP, Wheatley DJ, Prescott RJ, Miller HC. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N. Engl. J. Med. 324(9), 573-579 (1991
7. Rao PS, Solymar L, Mardini MK, Fawzy ME, Guinn G. Anticoagulant therapy in children with prosthetic valves. Ann. Thorac. Surg. 47(4), 589-592 (1989
8. Ross D, Jackson M, Davies J. Pulmonary autograft aortic valve replacement: Long-term results. J. Cardiac Surg. 6(Suppl. 4), S29-S33 (1991
9. Ross D, Jackson M, Davies J. The pulmonary autograft - a permanent aortic valve. Eur. J. Cardiothorac. Surg. 6(3), 113-116; discussion 117 (1992
10. Stewart RD, Backer CL, Hillman ND, Lundt C, Mavroudis C. The Ross operation in children: Effects of aortic annuloplasty. Ann. Thorac. Surg. 84(4), 1326-1330 (2007
11. Takkenberg JJ, Van Herwerden LA, Galema TW et al. Serial echocardiographic assessment of neo-aortic regurgitation and root dimensions after the modified Ross procedure. J. Heart Valve Dis. 15(1), 100-106; discussion 106-107 (2006
12. Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics - 2013 update: A report from the American Heart Association. Circulation 127(1), e6-e245 (2013
13. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J. Thorac. Cardiovasc. Surg. 137(1), 82-90 (2009
14. Kidane AG, Burriesci G, Edirisinghe M, Ghanbari H, Bonhoeffer P, Seifalian AM. A novel nanocomposite polymer for development of synthetic heart valve leaflets. Acta Biomater. 5(7), 2409-2417 (2009
15. Ghanbari H, Kidane AG, Burriesci G, Ramesh B, Darbyshire A, Seifalian AM. The anti-calcification potential of a silsesquioxane nanocomposite polymer under in vitro conditions: Potential material for synthetic leaflet heart valve. Acta Biomater. 6(11), 4249-4260 (2010
16. Ghanbari H, De Mel A, Seifalian AM. Cardiovascular application of polyhedral oligomeric silsesquioxane nanomaterials: A glimpse into prospective horizons. Int. J. Nanomed. 6, 775-786 (2011
17. Duan B, Hockaday LA, Kang KH, Butcher JT. 3D Bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels. J. Biomed. Mater. Res. A 101(5), 1255-1264 (2012
18. Hockaday LA, Kang KH, Colangelo NW et al. Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds. Biofabrication 4(3), 035005 (2012
19. Masters KS, Shah DN, Leinwand LA, Anseth KS. Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials 26(15), 2517-2525 (2005
20. Ramamurthi A, Vesely I. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials 26(9), 999-1010 (2005
21. Van Nooten G, Somers P, Cornelissen M et al. Acellular porcine and kangaroo aortic valve scaffolds show more intense immune-mediated calcification than cross-linked Toronto SPV valves in the sheep model. Interact. Cardiovasc. Thorac. Surg. 5(5), 544-549 (2006
22. Kasimir MT, Rieder E, Seebacher G et al. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J. Heart Valve Dis. 15(2), 278-286 (2006
23. Erdbrugger W, Konertz W, Dohmen PM et al. Decellularized xenogenic heart valves reveal remodeling and growth potential in vivo. Tissue Eng. 12(8), 2059-2068 (2006
24. Dohmen PM, Da Costa F, Holinski S et al. Is there a possibility for a glutaraldehyde-free porcine heart valve to grow? Eur. Surg. Res. 38(1), 54-61 (2006
25. Ott HC, Matthiesen TS, Goh SK et al. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat. Med. 14(2), 213-221 (2008
26. Tudorache I, Cebotari S, Sturz G et al. Tissue engineering of heart valves: Biomechanical and morphological properties of decellularized heart valves. J. Heart Valve Dis. 16(5), 567-573; discussion 574 (2007
27. Cebotari S, Tudorache I, Jaekel T et al. Detergent decellularization of heart valves for tissue engineering: Toxicological effects of residual detergents on human endothelial cells. Artif. Organs 34(3), 206-210 (2010
28. Liao J, Joyce EM, Sacks MS. Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. Biomaterials 29(8), 1065-1074 (2008
29. Yang M, Chen CZ, Wang XN, Zhu YB, Gu YJ. Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves. J. Biomed. Mater. Res. Part B Appl. Biomater. 91(1), 354-361 (2009
30. Rieder E, Kasimir MT, Silberhumer G et al. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J. Thorac. Cardiovasc. Surg. 127(2), 399-405 (2004
31. Gallo M, Naso F, Poser H et al. Physiological performance of a detergent decellularized heart valve implanted for 15 months in Vietnamese pigs: Surgical procedure, follow-up, and explant inspection. Artif. Organs 36(6), E138-E150 (2012
32. Iop L, Renier V, Naso F et al. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. Biomaterials 30(25), 4104-4116 (2009
33. Naso F, Gandaglia A, Formato M et al. Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. Acta Biomater. 6(12), 4675-4688 (2010
34. Naso F, Gandaglia A, Iop L, Spina M, Gerosa G. First quantitative assay of a-Gal in soft tissues: Presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. Acta Biomater. 7(4), 1728-1734 (2011
35. Lai VK, Frey CR, Kerandi AM, Lake SP, Tranquillo RT, Barocas VH. Microstructural and mechanical differences between digested collagen-fibrin co-gels and pure collagen and fibrin gels. Acta Biomater. 8(11), 4031-4042 (2012
36. Lai VK, Lake SP, Frey CR, Tranquillo RT, Barocas VH. Mechanical behavior of collagen-fibrin co-gels reflects transition from series to parallel interactions with increasing collagen content. J. Biomech. Eng. 134(1), 011004 (2012
37. Bjork JW, Meier LA, Johnson SL, Syedain ZH, Tranquillo RT. Hypoxic culture and insulin yield improvements to fibrin-based engineered tissue. Tissue Eng. Part A 18(7-8), 785-795 (2012
38. Syedain ZH, Bradee AR, Kren S, Taylor DA, Tranquillo RT. Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Eng. Part A 19(5-6), 759-769 (2012
39. Mol A, Driessen NJ, Rutten MC, Hoerstrup SP, Bouten CV, Baaijens FP. Tissue engineering of human heart valve leaflets: A novel bioreactor for a strain-based conditioning approach. Ann. Biomed. Eng. 33(12), 1778-1788 (2005
40. Hoerstrup SP, Sodian R, Daebritz S et al. Functional living trileaflet heart valves grown in vitro. Circulation 102(19 Suppl. 3), III44-III49 (2000
41. Sodian R, Hoerstrup SP, Sperling JS et al. Tissue engineering of heart valves: In vitro experiences. Ann. Thorac. Surg. 70(1), 140-144 (2000
42. Sodian R, Lueders C, Kraemer L et al. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Ann. Thorac. Surg. 81(6), 2207-2216 (2006
43. Del Gaudio C, Bianco A, Grigioni M. Electrospun bioresorbable trileaflet heart valve prosthesis for tissue engineering: In vitro functional assessment of a pulmonary cardiac valve design. Ann. Ist. Super. Sanita 44(2), 178-186 (2008
44. Del Gaudio C, Grigioni M, Bianco A, De Angelis G. Electrospun bioresorbable heart valve scaffold for tissue engineering. Int. J. Artif. Organs 31(1), 68-75 (2008
45. Courtney T, Sacks MS, Stankus J, Guan J, Wagner WR. Design and analysis of tissue engineering scaffolds that mimic soft tissue mechanical anisotropy. Biomaterials 27(19), 3631-3638 (2006
46. Mulholland DL, Gotlieb AI. Cell biology of valvular interstitial cells. Can. J. Cardiol. 12(3), 231-236 (1996
47. Dreger SA, Taylor PM, Allen SP, Yacoub MH. Profand localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. J. Heart Valve Dis. 11(6), 875-880; discussion 880 (2002
48. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am. J. Pathol. 171(5), 1407-1418 (2007
49. Shinoka T, Breuer CK, Tanel RE et al. Tissue engineering heart valves: Valve leaflet replacement study in a lamb model. Ann. Thorac. Surg. 60(Suppl. 6), S513-S516 (1995
50. Steinhoff G, Stock U, Karim N et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: In vivo restoration of valve tissue. Circulation 102(19 Suppl. 3), III50-III55 (2000
51. Vincentelli A, Wautot F, Juthier F et al. In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates? J. Thorac. Cardiovasc. Surg. 134(2), 424-432 (2007
52. Weber B, Scherman J, Emmert MY et al. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: First experiences with a one-step intervention in primates. Eur. Heart J. 32(22), 2830-2840 (2011
53. Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF. Ross operation with a tissue-engineered heart valve. Ann. Thorac. Surg. 74(5), 1438-1442 (2002
54. Frank BS, Toth PB, Wells WK et al. Determining cell seeding dosages for tissue engineering human pulmonary valves. J. Surg. Res. 174(1), 39-47 (2012
55. Perry TE, Kaushal S, Sutherland FW et al. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. Ann. Thorac. Surg. 75(3), 761-767; discussion 767 (2003
56. Sutherland FW, Perry TE, Yu Y et al. From stem cells to viable autologous semilunar heart valve. Circulation 111(21), 2783-2791 (2005
57. Sales VL, Mettler BA, Engelmayr GC Jr et al. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Tissue Eng. Part A 16(1), 257-267 (2010
58. Lee DJ, Steen J, Jordan JE et al. Endothelialization of heart valve matrix using a computer-assisted pulsatile bioreactor. Tissue Eng. Part A 15(4), 807-814 (2009
59. Schmidt D, Mol A, Odermatt B et al. Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. Tissue Eng. 12(11), 3223-3232 (2006
60. Bolli R, Chugh AR, D'Amario D et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised Phase 1 trial. Lancet 378(9806), 1847-1857 (2011
61. Makkar RR, Smith RR, Cheng K et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised Phase 1 trial. Lancet 379(9819), 895-904 (2012
62. Schenke-Layland K, Opitz F, Gross M et al. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals - an in vitro study. Cardiovasc. Res. 60(3), 497-509 (2003
63. Flanagan TC, Cornelissen C, Koch S et al. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials 28(23), 3388-3397 (2007
64. Robinson PS, Johnson SL, Evans MC, Barocas VH, Tranquillo RT. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue Eng. Part A 14(1), 83-95 (2008
65. Ramaswamy S, Gottlieb D, Engelmayr GC Jr et al. The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. Biomaterials 31(6), 1114-1125 (2010
66. Aleksieva G, Hollweck T, Thierfelder N et al. Use of a special bioreactor for the cultivation of a new flexible polyurethane scaffold for aortic valve tissue engineering. Biomed. Eng. Online 11, 92 (2012
67. Emmert MY, Weber B, Wolint P et al. Stem cell-based transcatheter aortic valve implantation: First experiences in a pre-clinical model. JACC Cardiovasc. Interv. 5(8), 874-883 (2012
68. Goldstein S, Clarke DR, Walsh SP, Black KS, O'Brien MF. Transpecies heart valve transplant: Advanced studies of a bioengineered xeno-autograft. Ann. Thorac. Surg. 70(6), 1962-1969 (2000
69. Elkins RC, Goldstein S, Hewitt CW et al. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin. Thorac. Cardiovasc. Surg. 13(4 Suppl. 1), S87-S92 (2001
70. Leyh RG, Wilhelmi M, Rebe P et al. In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation. Ann. Thorac. Surg. 75(5), 1457-1463; discussion 1463 (2003
71. Takagi K, Fukunaga S, Nishi A et al. In vivo recellularization of plain decellularized xenografts with specific cell characterization in the systemic circulation: Histological and immunohistochemical study. Artif. Organs 30(4), 233-241 (2006
72. Iwai S, Torikai K, Coppin CM, Sawa Y. Minimally immunogenic decellularized porcine valve provides in situ recellularization as a stentless bioprosthetic valve. J. Artif. Organs 10(1), 29-35 (2007
73. Jordan JE, Williams JK, Lee SJ, Raghavan D, Atala A, Yoo JJ. Bioengineered self-seeding heart valves. J. Thorac. Cardiovasc. Surg. 143(1), 201-208 (2012
74. Berry JL, Steen JA, Koudy Williams J, Jordan JE, Atala A, Yoo JJ. Bioreactors for development of tissue engineered heart valves. Ann. Biomed. Eng. 38(11), 3272-3279 (2010
75. Gandaglia A, Bagno A, Naso F, Spina M, Gerosa G. Cells, scaffolds and bioreactors for tissue-engineered heart valves: A journey from basic concepts to contemporary developmental innovations. Eur. J. Cardiothorac. Surg. 39(4), 523-531 (2011
76. Balachandran K, Bakay MA, Connolly JM, Zhang X, Yoganathan AP, Levy RJ. Aortic valve cyclic stretch causes increased remodeling activity and enhanced serotonin receptor responsiveness. Ann. Thorac. Surg. 92(1), 147-153 (2011
77. Ku CH, Johnson PH, Batten P et al. Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc. Res. 71(3), 548-556 (2006
78. Merryman WD, Lukoff HD, Long RA, Engelmayr GC Jr, Hopkins RA, Sacks MS. Synergistic effects of cyclic tension and transforming growth factor-b1 on the aortic valve myofibroblast. Cardiovasc. Pathol. 16(5), 268-276 (2007
79. Balachandran K, Konduri S, Sucosky P, Jo H, Yoganathan AP. An ex vivo study of the biological properties of porcine aortic valves in response to circumferential cyclic stretch. Ann. Biomed. Eng. 34(11), 1655-1665 (2006
80. Gupta V, Werdenberg JA, Lawrence BD, Mendez JS, Stephens EH, Grande-Allen KJ. Reversible secretion of glycosaminoglycans and proteoglycans by cyclically stretched valvular cells in 3D culture. Ann. Biomed. Eng. 36(7), 1092-1103 (2008
81. Engelmayr GC Jr, Rabkin E, Sutherland FW, Schoen FJ, Mayer JE Jr, Sacks MS. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials 26(2), 175-187 (2005
82. Engelmayr GC Jr, Sales VL, Mayer JE Jr, Sacks MS. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues. Biomaterials 27(36), 6083-6095 (2006
83. Jockenhoevel S, Zund G, Hoerstrup SP, Schnell A, Turina M. Cardiovascular tissue engineering: A new laminar flow chamber for in vitro improvement of mechanical tissue properties. ASAIO J. 48(1), 8-11 (2002
84. Butcher JT, Penrod AM, Garcia AJ, Nerem RM. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler. Thromb. Vasc. Biol. 24(8), 1429-1434 (2004
85. Butcher JT, Tressel S, Johnson T et al. Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences: Influence of shear stress. Arterioscler. Thromb. Vasc. Biol. 26(1), 69-77 (2006
86. Butcher JT, Nerem RM. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: Effects of steady shear stress. Tissue Eng. 12(4), 905-915 (2006
87. Xing Y, He Z, Warnock JN, Hilbert SL, Yoganathan AP. Effects of constant static pressure on the biological properties of porcine aortic valve leaflets. Ann. Biomed. Eng. 32(4), 555-562 (2004
88. Xing Y, Warnock JN, He Z, Hilbert SL, Yoganathan AP. Cyclic pressure affects the biological properties of porcine aortic valve leaflets in a magnitude and frequency dependent manner. Ann. Biomed. Eng. 32(11), 1461-1470 (2004
89. Ikhumetse JD, Konduri S, Warnock JN, Xing Y, Yoganathand AP. Cyclic aortic pressure affects the biological properties of porcine pulmonary valve leaflets. J. Heart Valve Dis. 15(2), 295-302 (2006
90. Ota T, Sawa Y, Iwai S et al. Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve. Ann. Thorac. Surg. 80(5), 1794-1801 (2005
91. Long JL, Tranquillo RT. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol. 22(4), 339-350 (2003
92. Huang SD, Liu XH, Bai CG et al. Synergistic effect of fibronectin and hepatocyte growth factor on stable cell-matrix adhesion, re-endothelialization, and reconstitution in developing tissue-engineered heart valves. Heart Vessels 22(2), 116-122 (2007
93. Hoerstrup SP, Zund G, Schnell AM et al. Optimized growth conditions for tissue engineering of human cardiovascular structures. Int. J. Artif. Organs 23(12), 817-823 (2000
94. Narine K, De Wever O, Van Valckenborgh D et al. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: Implications for tissue valve engineering. Tissue Eng. 12(10), 2707-2716 (2006
95. Dvorin EL, Wylie-Sears J, Kaushal S, Martin DP, Bischoff J. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: Proliferation and differentiation on poly-glycolic acid/ poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor b1. Tissue Eng. 9(3), 487-493 (2003
96. Johnson EN, Lee YM, Sander TL et al. NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J. Biol. Chem. 278(3), 1686-1692 (2003
97. Ruel J, Lachance G. Mathematical modeling and experimental testing of three bioreactor configurations based on windkessel models. Heart Int. 5(1), e1 (2010
98. Lichtenberg A, Tudorache I, Cebotari S et al. In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions. Biomaterials 27(23), 4221-4229 (2006
99. Hildebrand DK, Wu ZJ, Mayer JE Jr, Sacks MS. Design and hydrodynamic evaluation of a novel pulsatile bioreactor for biologically active heart valves. Ann. Biomed. Eng. 32(8), 1039-1049 (2004
100. Sierad LN, Simionescu A, Albers C et al. Design and testing of a pulsatile conditioning system for dynamic endothelialization of polyphenol-stabilized tissue engineered heart valves. Cardiovasc. Eng. Technol. 1(2), 138-153 (2010
101. Kaasi A, Cestari IA, Stolf NA, Leirner AA, Hassager O, Cestari IN. A new approach to heart valve tissue engineering: Mimicking the heart ventricle with a ventricular assist device in a novel bioreactor. J. Tissue Eng. Regen. Med. 5(4), 292-300 (2011
102. Kortsmit J, Rutten MC, Wijlaars MW, Baaijens FP. Deformation-controlled load application in heart valve tissue engineering. Tissue Eng. Part C Methods 15(4), 707-716 (2009
103. Vismara R, Soncini M, Talo G et al. A bioreactor with compliance monitoring for heart valve grafts. Ann. Biomed. Eng. 38(1), 100-108 (2010
104. Kortsmit J, Driessen NJ, Rutten MC, Baaijens FP. Real time, non-invasive assessment of leaflet deformation in heart valve tissue engineering. Ann. Biomed. Eng. 37(3), 532-541 (2009
105. Syedain ZH, Tranquillo RT. Controlled cyclic stretch bioreactor for tissue-engineered heart valves. Biomaterials 30(25), 4078-4084 (2009
106. Narita Y, Hata K, Kagami H, Usui A, Ueda M, Ueda Y. Novel pulse duplicating bioreactor system for tissue-engineered vascular construct. Tissue Eng. 10(7-8), 1224-1233 (2004
107. Ziegelmueller JA, Zaenkert EK, Schams R et al. Optical monitoring during bioreactor conditioning of tissue-engineered heart valves. ASAIO J. 56(3), 228-231 (2010
108. Konig F, Hollweck T, Pfeifer S et al. A pulsatile bioreactor for conditioning of tissue-engineered cardiovascular constructs under endoscopic visualization. J. Funct. Biomater. 3, 480-496 (2012
109. Metzler SA, Digesu CS, Howard JI, Filip To SD, Warnock JN. Live en face imaging of aortic valve leaflets under mechanical stress. Biomech. Model Mechanobiol. 11(3-4), 355-361 (2012
110. Hoerstrup SP, Sodian R, Sperling JS, Vacanti JP, Mayer JE Jr. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng. 6(1), 75-79 (2000
111. Dumont K, Yperman J, Verbeken E et al. Design of a new pulsatile bioreactor for tissue engineered aortic heart valve formation. Artif. Organs 26(8), 710-714 (2002
112. Mol A, Bouten CV, Zund G et al. The relevance of large strains in functional tissue engineering of heart valves. Thorac. Cardiovasc. Surg. 51(2), 78-83 (2003
113. Mol A, Rutten MC, Driessen NJ et al. Autologous human tissue-engineered heart valves: Prospects for systemic application. Circulation 114(Suppl. 1), I152-I158 (2006
114. Engelmayr GC Jr, Hildebrand DK, Sutherland FW, Mayer JE Jr, Sacks MS. A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials 24(14), 2523-2532 (2003
115. Gould RA, Chin K, Santisakultarm TP et al. Cyclic strain anisotropy regulates valvular interstitial cell phenotype and tissue remodeling in three-dimensional culture. Acta Biomater. 8(5), 1710-1719 (2012
116. Weston MW, Yoganathan AP. Biosynthetic activity in heart valve leaflets in response to in vitro flow environments. Ann. Biomed. Eng. 29(9), 752-763 (2001
117. Barzilla JE, Mckenney AS, Cowan AE, Durst CA, Grande-Allen KJ. Design and validation of a novel splashing bioreactor system for use in mitral valve organ culture. Ann. Biomed. Eng. 38(11), 3280-3294 (2010
118. Sun L, Rajamannan NM, Sucosky P. Design and validation of a novel bioreactor to subject aortic valve leaflets to side-specific shear stress. Ann. Biomed. Eng. 39(8), 2174-2185 (2011
119. Schipke KJ, To SD, Warnock JN. Design of a cyclic pressure bioreactor for the ex vivo study of aortic heart valves. J. Vis. Exp. (54), e3316 (2011
120. Engelmayr GC Jr, Soletti L, Vigmostad SC et al. A novel flex-stretch-flow bioreactor for the study of engineered heart valve tissue mechanobiology. Ann. Biomed. Eng. 36(5), 700-712 (2008
121. Gallegos RP, Nockel PJ, Rivard AL, Bianco RW. The current state of in-vivo pre-clinical animal models for heart valve evaluation. J. Heart Valve Dis. 14(3), 423-432 (2005
122. Schoen FJ. Pathologic findings in explanted clinical bioprosthetic valves fabricated from photooxidized bovine pericardium. J. Heart Valve Dis. 7(2), 174-179 (1998
123. Mendelson K, Schoen FJ. Heart valve tissue engineering: Concepts, approaches, progress, and challenges. Ann. Biomed. Eng. 34(12), 1799-1819 (2006
124. Simon P, Kasimir MT, Seebacher G et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur. J. Cardiothorac. Surg. 23(6), 1002-1006; discussion 1006 (2003
125. Perri G, Polito A, Esposito C et al. Early and late failure of tissue-engineered pulmonary valve conduits used for right ventricular outflow tract reconstruction in patients with congenital heart disease. Eur. J. Cardiothorac. Surg. 41(6), 1320-1325 (2012
126. Hjortnaes J, Bouten CV, Van Herwerden LA, Grundeman PF, Kluin J. Translating autologous heart valve tissue engineering from bench to bed. Tissue Eng. Part B Rev. 15(3), 307-317 (2009
127. Rahimtoola SH. The next generation of prosthetic heart valves needs a proven track record of patient outcomes at > or =15 to 20 years. J. Am. Coll. Cardiol. 42(10), 1720-1721 (2003
128. Durst CA, Grande-Allen KJ. Design and physical characterization of a synchronous multivalve aortic valve culture system. Ann. Biomed. Eng. 38(2), 319-325 (2010
129. Ruel J, Lachance G. A new bioreactor for the development of tissue-engineered heart valves. Ann. Biomed. Eng. 37(4), 674-681 (2009
130. Migneco F, Hollister SJ, Birla RK. Tissue-engineered heart valve prostheses: 'state of the heart'. Regen. Med. 3(3), 399-419 (2008
131. Morsi YS, Yang WW, Owida A, Wong CS. Development of a novel pulsatile bioreactor for tissue culture. J. Artif. Organs 10(2), 109-114 (2007
132. Karim N, Golz K, Bader A. The cardiovascular tissue-reactor: A novel device for the engineering of heart valves. Artif. Organs 30(10), 809-814 (2006
133. Warnock JN, Konduri S, He Z, Yoganathan AP. Design of a sterile organ culture system for the ex vivo study of aortic heart valves. J. Biomech. Eng. 127(5), 857-861 (2005
134. Zeltinger J, Landeen LK, Alexander HG, Kidd ID, Sibanda B. Development and characterization of tissue-engineered aortic valves. Tissue Eng. 7(1), 9-22 (2001